JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M410066200 on January 11, 2005

J. Biol. Chem., Vol. 280, Issue 12, 10925-10937, March 25, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/12/10925    most recent
M410066200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morty, R. E.
Right arrow Articles by Bubis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morty, R. E.
Right arrow Articles by Bubis, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Oligopeptidase B from Trypanosoma evansi

A PARASITE PEPTIDASE THAT INACTIVATES ATRIAL NATRIURETIC FACTOR IN THE BLOODSTREAM OF INFECTED HOSTS*

Rory E. Morty{ddagger}§, Roger Pellé¶, István Vadász{ddagger}, Graciela L. Uzcanga||**, Werner Seeger{ddagger}, and José Bubis**

From the {ddagger}Department of Internal Medicine, University of Giessen Medical Centre, Aulweg 123 (Raum 6-11), D-35392 Giessen, Germany, the International Livestock Research Institute, P. O. Box 30709, Nairobi, Kenya, and the **Departamento de Biología Celular, Universidad Simón Bolívar, Apartado 89.000, Valle de Sartenejas, Caracas 1081-A, Venezuela

Serine oligopeptidases of trypanosomatids are emerging as important virulence factors and therapeutic targets in trypanosome infections. We report here the isolation and characterization of oligopeptidase B (OpdB) and its corresponding gene from Trypanosoma evansi, a pathogen of significant veterinary importance. The T. evansi opdB gene was present as a single copy per haploid genome containing an open reading frame of 2148 bp encoding a protein of 80.664 kDa. Purified OpdB hydrolyzed substrates with basic residues in P1 (kcat/Km for carbobenzyloxy-L-arginyl-L-arginyl-7-amido-4-methylcoumarin, 337 s–1·µM–1) and exhibited potent arginyl carboxypeptidase activity (kcat/Km for Val-Lys-Arg{downarrow}Arg-OH, 231 s–1·mM–1). While not secreted, T. evansi released OpdB into the plasma of infected hosts where it retained catalytic activity. Plasma OpdB levels correlated with blood parasitemia. In vitro, OpdB cleaved the peptide hormone atrial natriuretic factor (ANF) at four sites: Arg3{downarrow}Arg4, Arg4{downarrow}Ser5, Arg11{downarrow}Ile12, and Arg27{downarrow}Tyr28, thereby abrogating smooth muscle relaxant and prohypotensive properties of ANF. Circulating plasma ANF levels in T. evansi-infected rats were depressed from 130 to 8 pg·ml–1, and plasma ANF levels inversely correlated with plasma OpdB activity. The in vitro half-life of ANF in rat plasma was reduced 300-fold in plasma from T. evansi-infected rodents, which contains high levels of OpdB activity. Addition of OpdB inhibitors to cell-free plasma from infected rodents significantly abrogated this ANF hydrolysis. Furthermore the in vivo ANF half-life was reduced 5-fold in T. evansi-infected rats. Thus, we propose a role for OpdB in peptide hormone dysregulation in trypanosomiasis, specifically in generating the depressed plasma levels of ANF in mammals infected with T. evansi.


Received for publication, September 1, 2004 , and in revised form, January 10, 2005.

* This work was supported by grants from the Alexander von Humboldt Foundation (to R. E. M.), the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 547: "Kardiopulmonales Gefässsystem" (to R. E. M., I. V., and W. S.), and Fondo Nacional de Ciencia, Tecnología e Innovación Grant G-2000001152 (to J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY546084.

|| Present address: Dept. de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Avenida Puerta de Hierro s/n, 28040 Madrid, Spain.

§ To whom correspondence should be addressed. Tel: 49-(641)-994-2303; Fax: 49-(641)-994-2308; E-mail: rory.morty{at}innere.med.unigiessen.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.